Consolidated Statements of Operations and Comprehensive Loss - USD ($) |
12 Months Ended | |
|---|---|---|
Feb. 28, 2021 |
Feb. 29, 2020 |
|
| Statement of Comprehensive Income [Abstract] | ||
| Revenue | $ 0 | $ 0 |
| Operating Expenses | ||
| Research and development (Notes 13 and 15) | 18,687,014 | 4,717,175 |
| General and administrative (Notes 14 and 15) | 11,540,340 | 7,215,420 |
| Write-down and impairment of property, plant and equipment (Note 5) | 5,043,119 | 22,985 |
| Depreciation and amortization (Notes 4 and 5) | 775,675 | 807,447 |
| Interest and other financial expenses (Note 18) | 81,996 | 2,223,304 |
| Interest income | (93,043) | (500,478) |
| Foreign exchange loss (gain) | 309,822 | 19,602 |
| Total operating expenses | 36,344,923 | 14,505,455 |
| Net loss | (36,344,923) | (14,505,455) |
| Other Comprehensive Loss | ||
| Foreign currency translation adjustment | 381,859 | (98,225) |
| Comprehensive loss | $ (35,963,064) | $ (14,603,680) |
| Loss per share | ||
| Basic and diluted | $ (0.89) | $ (0.38) |
| Weighted average common shares outstanding | ||
| Basic and diluted | 40,983,752 | 37,936,094 |